Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility
about
Extended-spectrum beta-lactamases: a clinical updatePlasmid-determined AmpC-type beta-lactamases.Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threatDetection and clinical significance of extended-spectrum beta-lactamases in a tertiary-care medical centerbeta-Lactamases in laboratory and clinical resistanceA functional classification scheme for beta-lactamases and its correlation with molecular structureEnterobacter spp.: pathogens poised to flourish at the turn of the centuryApplication of the development stages of a cluster randomized trial to a framework for valuating complex health interventions.Maintaining fluoroquinolone class efficacy: review of influencing factors.Extended-spectrum beta-lactamases and clinical outcomes: current data.Issues in the management of resistant bacteria in long-term-care facilities.Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of beta-lactamase production among escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonaEpidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases.A novel extended-spectrum TEM-type beta-lactamase (TEM-52) associated with decreased susceptibility to moxalactam in Klebsiella pneumoniaePlasmid-mediated resistance to expanded-spectrum cephalosporins among Enterobacter aerogenes strainsOutbreak of ceftazidime-resistant Klebsiella pneumoniae in a pediatric hospital in Warsaw, Poland: clonal spread of the TEM-47 extended-spectrum beta-lactamase (ESBL)-producing strain and transfer of a plasmid carrying the SHV-5-like ESBL-encoding gSuccessful interventions for gram-negative resistance to extended-spectrum beta-lactam antiobiotics.Identification of TEM-26 beta-lactamase responsible for a major outbreak of ceftazidime-resistant Klebsiella pneumoniaeMultiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing beta-lactamases in a single isolate.Requirements for infrastructure and essential activities of infection control and epidemiology in out-of-hospital settings: a consensus panel report. Association for Professionals in Infection Control and Epidemiology and Society for Healthcare EpidCommunity-wide outbreaks of clonally related CTX-M-14 beta-lactamase-producing Escherichia coli strains in the Calgary health regionPrevalence of AmpC and other beta-lactamases in enterobacteria at a large urban university hospital in Brazil.Detection and reporting of organisms producing extended-spectrum beta-lactamases: survey of laboratories in Connecticut.Coexistence of SHV-4- and TEM-24-producing Enterobacter aerogenes strains before a large outbreak of TEM-24-producing strains in a French hospitalOutcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory.Development of resistance during antimicrobial therapy caused by insertion sequence interruption of porin genes.Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniaeCharacterization of the extended-spectrum beta-lactamase reference strain, Klebsiella pneumoniae K6 (ATCC 700603), which produces the novel enzyme SHV-18Evaluation of current activities of fluoroquinolones against gram-negative bacilli using centralized in vitro testing and electronic surveillance.Evidence for transfer of CMY-2 AmpC beta-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals and humans.Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae.Identification and characterization of a new porin gene of Klebsiella pneumoniae: its role in beta-lactam antibiotic resistance.SHV-type extended-spectrum beta-lactamase production is associated with Reduced cefepime susceptibility in Enterobacter cloacaeEmerging issues in antibiotic resistance in blood-borne infections.Antibiotic use in long-term-care facilities: many unanswered questions.Multiple antibiotic-resistant bacteria in long-term-care facilities: An emerging problem in the practice of infectious diseases.Development of minimum criteria for the initiation of antibiotics in residents of long-term-care facilities: results of a consensus conference.Prevalence of extended-spectrum beta-lactamase-producing Enterobacter cloacae in the Asia-Pacific region: results from the SENTRY Antimicrobial Surveillance Program, 1998 to 2001.Amino acid substitutions at Ambler position Gly238 in the SHV-1 beta-lactamase: exploring sequence requirements for resistance to penicillins and cephalosporins.Increasing prevalence of ESBL production among Irish clinical Enterobacteriaceae from 2004 to 2008: an observational study.
P2860
Q24534999-7542C439-5C6F-41C8-B2BB-36A4002E7794Q24535748-9C3F27FC-7D72-4E25-BB9F-27A72BB1660DQ24550671-FBA8E35A-4116-4BCF-AC09-09947E557F37Q24653870-49D14090-D760-43A4-ABD7-B5DE744A6B8DQ24669605-2A7A316B-BCA4-43A6-A4B0-F50ED6A2E799Q24677460-E34BA655-D7AE-4EC5-B0E7-A3E2CA8EC3B9Q24683746-DDD9CE26-D9B4-4C1A-B4BA-19CF0474D2EEQ24797744-435EB535-A5F1-4426-8C5D-CBE2D880E42BQ30310427-F66FBAF6-9999-4157-AEBE-DD902BC70BF3Q33236875-66ED6F39-9CEC-4983-A930-2D8BAE7311B0Q33647776-0CB59A5E-6D07-47E2-B77D-5256398F5649Q33682354-1AE0F194-60CA-435E-ADF1-761F7513EBA0Q33690464-6FA4F44D-50CC-45EC-AD77-A3695F2A7CFEQ33690561-A0C5DABD-A97F-426D-BA94-CBA8F6F930D0Q33691113-47426CC7-BB9A-4DB9-B3A6-0881F97834C8Q33702657-EF60BB56-E38D-4C1A-9D78-50EF3060F717Q33717167-AF9B83DB-0F69-4D1C-99AF-9CDEF6265C0DQ33750083-E1453868-F418-435D-9352-29D2DCC49AADQ33752745-07A71D9C-1D01-4C7A-B34F-8C23AF2E0174Q33756684-8F600A14-21EE-4EE2-AB1A-47DBFD5A2F9DQ33856392-05DBAC01-C6A7-4464-B3E9-9064C829E573Q33949179-B7D983FE-50E8-4A51-91DC-807C9260E7C2Q33964309-FE36E15C-DBAC-489E-BB04-D0E2A8C07F1FQ33972569-66A8AF53-253A-4461-B7CD-A1E98BFA5F7BQ33972587-C6BB5B9A-6E9D-4D0B-843B-5A8713217CFEQ33976721-A7931C4C-6CDD-42FB-A16D-F40EF008BED0Q33977146-EA30483F-7184-4465-9BAF-86B9A11C559EQ33980456-D3517A6A-651E-444D-B1EE-9F13469C0B0DQ33981224-28413D73-D9AE-4BB3-941D-8C1909AEA76EQ33983055-007DEB16-B657-405F-8424-9E563F530917Q33983667-10F92320-BB39-40C4-88DF-F5362D09DDF5Q33991864-185E1949-358A-4904-BA75-C811C7B98597Q34073514-41793D2C-BE1C-4C77-852A-FB5819F3F694Q34078706-4CBE04FF-46BB-4A76-B350-F9DDB457D735Q34085031-2D7ECA7D-30D6-4464-A34A-2CE0AEA8C75BQ34092336-60393B9D-9C6C-453E-BEF0-714F69349F19Q34171540-34CB31F1-5172-41F4-8328-7BBCA61CF1A4Q34229879-75220779-7B9B-4E16-AE9B-670F30B56831Q34253358-054B84B6-CACF-4533-8234-1553C3C54784Q34269727-A723A727-DA4D-4B29-8DE5-8F5B95E73AC9
P2860
Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility
description
1990 nî lūn-bûn
@nan
1990 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Outbreak of ceftazidime resist ...... chusetts chronic-care facility
@ast
Outbreak of ceftazidime resist ...... chusetts chronic-care facility
@en
type
label
Outbreak of ceftazidime resist ...... chusetts chronic-care facility
@ast
Outbreak of ceftazidime resist ...... chusetts chronic-care facility
@en
prefLabel
Outbreak of ceftazidime resist ...... chusetts chronic-care facility
@ast
Outbreak of ceftazidime resist ...... chusetts chronic-care facility
@en
P2093
P2860
P356
P1476
Outbreak of ceftazidime resist ...... chusetts chronic-care facility
@en
P2093
A A Medeiros
G A Jacoby
G A Papanicolaou
G M Eliopoulos
R C Moellering
S H Willey
P2860
P304
P356
10.1128/AAC.34.11.2193
P407
P577
1990-11-01T00:00:00Z